Pharmaceuticals Subscribe

Uterine Fibroids – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Uterine Fibroids – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Uterine Fibroids – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Uterine Fibroids, complete with latest […]

Neurodegenerative Diseases – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Neurodegenerative Diseases – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Neurodegenerative Diseases – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neurodegenerative Diseases, complete with latest […]

Metabolic Syndrome – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Metabolic Syndrome – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Metabolic Syndrome – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metabolic Syndrome, complete with latest […]

Other Metabolic Disorders – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Other Metabolic Disorders – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Other Metabolic Disorders – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Metabolic Disorders, […]

Cat Allergy – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Cat Allergy – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Cat Allergy – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cat Allergy, complete with latest […]

Cancer Pain – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Cancer Pain – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Cancer Pain – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cancer Pain, complete with latest […]

Polycystic Kidney Disease – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Polycystic Kidney Disease – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Polycystic Kidney Disease – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, […]

Bone Cancer – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Bone Cancer – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Bone Cancer – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bone Cancer, complete with latest […]

Organophosphate And Carbamate Poisoning – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Organophosphate And Carbamate Poisoning – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Organophosphate And Carbamate Poisoning – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Organophosphate […]

Peritoneal Tumor – Pipeline Review, H2 2013

Published in Sep 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Peritoneal Tumor – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Peritoneal Tumor – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Tumor, complete with latest […]